Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: Protocol for a network meta-analysis of randomized and observational studies

BACKGROUND: Patients undergoing renal transplant procedures require multi-agent immunosuppressive regimens both short term (induction phase) and long term (maintenance phase) to minimize the risk of organ rejection. There are several drug classes and agents for immunosuppression. Use of these agents...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hutton, Brian, Joseph, Lawrence, Yazdi, Fatemeh, Tetzlaff, Jennifer, Hersi, Mona, Kokolo, Madzouka, Fergusson, Nicolas, Bennett, Alexandria, Buenaventura, Chieny, Fergusson, Dean, Tricco, Andrea, Strauss, Sharon, Moher, David, Knoll, Greg
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3936935/
https://ncbi.nlm.nih.gov/pubmed/24559430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-3-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars